Groupe Berkem SA
PAR:ALKEM
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Intrinsic Value
Berkem SA produces, sells, and distributes chemical and vegetal extracts. [ Read More ]
The intrinsic value of one ALKEM stock under the Base Case scenario is 4.691 EUR. Compared to the current market price of 1.775 EUR, Groupe Berkem SA is Undervalued by 62%.
Valuation Backtest
Groupe Berkem SA
Run backtest to discover the historical profit from buying and selling ALKEM stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Groupe Berkem SA
Current Assets | 43.7m |
Cash & Short-Term Investments | 11.4m |
Receivables | 18.7m |
Other Current Assets | 13.7m |
Non-Current Assets | 50m |
Long-Term Investments | 19k |
PP&E | 26.1m |
Intangibles | 21.8m |
Other Non-Current Assets | 2.1m |
Current Liabilities | 34m |
Accounts Payable | -1k |
Accrued Liabilities | 2.1m |
Short-Term Debt | 56k |
Other Current Liabilities | 31.9m |
Non-Current Liabilities | 32m |
Long-Term Debt | 29.7m |
Other Non-Current Liabilities | 2.2m |
Earnings Waterfall
Groupe Berkem SA
Revenue
|
51.9m
EUR
|
Cost of Revenue
|
-23.2m
EUR
|
Gross Profit
|
28.7m
EUR
|
Operating Expenses
|
-25.9m
EUR
|
Operating Income
|
2.8m
EUR
|
Other Expenses
|
-2.4m
EUR
|
Net Income
|
367k
EUR
|
Free Cash Flow Analysis
Groupe Berkem SA
EUR | |
Free Cash Flow | EUR |
ALKEM Profitability Score
Profitability Due Diligence
Groupe Berkem SA's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
Groupe Berkem SA's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
ALKEM Solvency Score
Solvency Due Diligence
Groupe Berkem SA's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Groupe Berkem SA's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ALKEM Price Targets Summary
Groupe Berkem SA
According to Wall Street analysts, the average 1-year price target for ALKEM is 4.726 EUR with a low forecast of 4.444 EUR and a high forecast of 5.25 EUR.
Shareholder Return
ALKEM Price
Groupe Berkem SA
Average Annual Return | -21.94% |
Standard Deviation of Annual Returns | 39.75% |
Max Drawdown | -89% |
Market Capitalization | 31.4m EUR |
Shares Outstanding | 17 741 200 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Berkem SA produces, sells, and distributes chemical and vegetal extracts. The company is headquartered in Blanquefort, Occitanie. The company went IPO on 2021-12-08. The firm is engaged in the chemical sector industry, and it manages four subsidiaries: Berkem, Adkalis, Lixol, Eurolyo. The first business activity, which is led by Berkem, is specialised in plant extraction. The company targets the cosmetics and food industries, which itsupplies in natural active ingredients and plant extracts for use in formulation. The second division, represented by Eurolyo, offers its services in the freeze-drying of raw materials and finished products. The third, Adkalis, produces and distributes solutions that add value to building materials, wood in particular. These product lines are destined for more technical markets: wood processing markets (sawmills, carpenters, joiners, panel manufacturers, fitters, etc.) and the building industry (construction and maintenance-renovation). The fourth pole, Lixol, is specialized in the manufacturing of industrial resins for the paint, construction, timber treatment and ink industries.
Contact
IPO
Employees
Officers
The intrinsic value of one ALKEM stock under the Base Case scenario is 4.691 EUR.
Compared to the current market price of 1.775 EUR, Groupe Berkem SA is Undervalued by 62%.